DOUBLENATURAL INC – Trademark Portfolio
Entity Type: 03
DOUBLENATURAL INC holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 3 Nice Classification classes. Currently, 13 trademarks are registered. Notable registered marks include OCNAKOC, QVVLVEX, TUIIOOS, VIOMBOT, and DAUBLNATUR. The owner is based in West Palm Beach, FL.
Penthouse 2019, 5600 North Flagler Blvd
West Palm Beach, FL 33407
Showing of trademarks Trademarks
Trademark Classifications
DOUBLENATURAL INC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does DOUBLENATURAL INC have?
DOUBLENATURAL INC has 13 U.S. trademarks filed with the USPTO. Of these, 13 registered.
What trademark classes does DOUBLENATURAL INC file in?
DOUBLENATURAL INC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are DOUBLENATURAL INC's most well-known trademarks?
DOUBLENATURAL INC's registered trademark portfolio includes well-known marks such as OCNAKOC, QVVLVEX, TUIIOOS, VIOMBOT, and DAUBLNATUR. These are among 13 currently registered trademarks in the portfolio.
What is DOUBLENATURAL INC's trademark registration success rate?
DOUBLENATURAL INC has a 100% trademark registration rate, with 13 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.